Cholesterol trafficking to the ER leads to the activation of CaMKII/JNK/NLRP3 and promotes atherosclerosis
Journal of Lipid Research · 2024-04 · 65 (4) · 100534
DOI: 10.1016/j.jlr.2024.100534 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Lipid Research, 2024-04. Verfasst von Mustafa Yalcinkaya und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA. Electronic address: my2673@cumc…. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Atherosclerosis, Cholesterol, Calcium-Calmodulin-Dependent Protein Kinase Type 2. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NHLBI NIH HHS, NCRR NIH HHS.
Abstract (Originalsprache)
The deposition of cholesterol-rich lipoproteins in the arterial wall triggers macrophage inflammatory responses, which promote atherosclerosis. The NLRP3 inflammasome aggravates atherosclerosis; however, cellular mechanisms connecting macrophage cholesterol accumulation to inflammasome activation are poorly understood. We investigated the mechanisms of NLRP3 inflammasome activation in cholesterol-loaded macrophages and in atherosclerosis-prone Ldlr-/- mice with defects in macrophage cholesterol efflux. We found that accumulation of cholesterol in macrophages treated with modified LDL or cholesterol crystals, or in macrophages defective in the cholesterol efflux promoting transporters ABCA1 and ABCG1, leads to activation of NLRP3 inflammasomes as a result of increased cholesterol trafficking from the plasma membrane to the ER, via Aster-B. In turn, the accumulation of cholesterol in the ER activates the inositol triphosphate-3 receptor, CaMKII/JNK, and induces NLRP3 deubiquitylation by BRCC3. An NLRP3 deubiquitylation inhibitor or deficiency of Abro1, an essential scaffolding protein in the BRCC3-containing cytosolic complex, suppressed inflammasome activation, neutrophil extracellular trap formation (NETosis), and atherosclerosis in vivo. These results identify a link between the trafficking of cholesterol to the ER, NLRP3 deubiquitylation, inflammasome activation, and atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA. Electronic address: my2673@cumc.columbia.edu.
- Division of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
- Division of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA; Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, Th…
- Division of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA. Electronic address: art1@cumc.columbia.edu.
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
- NCRR NIH HHS
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- National Cancer Institute
- National Institutes of Health
Zitieren
APA
Yalcinkaya, M., Liu, W., Xiao, T., Abramowicz, S., Wang, R., Wang, N., Westerterp, M., & Tall, A. R. (2024). Cholesterol trafficking to the ER leads to the activation of CaMKII/JNK/NLRP3 and promotes atherosclerosis. Journal of Lipid Research, 65(4), 100534. https://doi.org/10.1016/j.jlr.2024.100534
Vancouver
Yalcinkaya M, Liu W, Xiao T, Abramowicz S, Wang R, Wang N, et al. Cholesterol trafficking to the ER leads to the activation of CaMKII/JNK/NLRP3 and promotes atherosclerosis. Journal of Lipid Research. 2024;65(4):100534. doi:10.1016/j.jlr.2024.100534
BibTeX
@article{Yalcinkaya2024,
author = {Yalcinkaya, Mustafa and Liu, Wenli and Xiao, Tong and Abramowicz, Sandra and Wang, Ranran and Wang, Nan and Westerterp, Marit and Tall, Alan R},
title = {Cholesterol trafficking to the ER leads to the activation of CaMKII/JNK/NLRP3 and promotes atherosclerosis},
journal = {Journal of Lipid Research},
year = {2024},
volume = {65},
number = {4},
pages = {100534},
doi = {10.1016/j.jlr.2024.100534}
}
EUVIMED